spacer
home > pmps > spring 2018 > optimising outsourcing
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Optimising Outsourcing

Over the last decade, the European pharmaceutical market has experienced a healthy growth rate and developed a steady track record in terms of regulatory progress, with the industry now holding the title of the fifth largest in the continent (1).

The market’s trade surplus, investment into R&D, and highly skilled workforce makes it a competitive market for pharma development and manufacturing services. While the majority of pharma outsourcing takes place in Western Europe, Central and Eastern European (CEE) countries are becoming increasingly popular alternatives.

The CEE market combines a cost-effective service with a progressive approach to R&D activity, all carried out within the EU regulatory environment, meaning companies outsourcing to partners in the region can be confident in the quality of the products manufactured.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
With over 25 years’ experience in the industry, Markus Saal has held positions in a number of leading pharma, biopharmaceutical, and medical device companies. As CDMO Sales Director at Saneca Pharma, he is responsible for driving the sales and business development activity for the CDMO and leading its strategic growth plan forwards.
spacer
Markus Saal
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation Pvt. Ltd. for cGMP Quaternary Ammonium Compounds for pharmaceutical and medical device applications

Novo Nordisk Pharmatech A/S has entered into an agreement with Signet Chemical Corporation Pvt. Ltd. for the distribution of their pharmaceutical range of quaternary ammonium compounds (FEF® Quats) to the healthcare industry in India, Bangladesh and Sri Lanka.
More info >>

White Papers

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology

European Society for Medical Oncology (ESMO)

  The number of cancer patients in Europe is rising and significant advances in basic and applied cancer research are making the provision of optimal care more challenging. The concept of cancer as a systemic, highly heterogeneous and complex disease has increased the awareness that quality cancer care should be provided by a multidisciplinary team (MDT) of highly qualified healthcare professionals. Cancer patients also have the right to benefit from medical progress by receiving optimal treatment from adequately trained and highly skilled medical professionals. Built on the highest standards of professional training and continuing medical education, medical oncology is recognised as an independent medical specialty in many European countries.
More info >>

 
Industry Events

PDA Universe of Pre-Filled Syringes and Injection Devices

8 October - 9 November 2018, Loews Royal Pacific, Orlando, FL

At the 2018 PDA Universe of Pre-filled Syringes and Injection Devices,industry and regulatory experts will share experiences, new developments, regulatory considerations, challenges, and industry trends and best practices. This is a must-attend event for all industry professionals involved in the development, manufacturing, testing, or marketing of pre-filled syringes and injection devices.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement